GeneDx Holdings WGS Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 69.7%+6.1pp | 63.6%+19.2pp | 44.4%+55.8pp | -11.4%-3.6pp | |
| Operating margin | -3.1%— | —— | -89.2%+195pp | -284.5%-74.2pp | |
| Net margin | -4.9%— | —— | -86.8%+147pp | -233.9%-118pp | |
| Returns | |||||
| Return on equity | -7.6%— | —— | -73%+98.1pp | -171.1%— | |
| Return on invested capital | -4.4%— | —— | -82.2%+548pp | -629.9%— | |
| Efficiency | |||||
| Asset turnover | 0.9×+0.2× | 0.7×+0.3× | 0.4×0.0× | 0.4×-0.1× | |
| Liquidity | |||||
| Current ratio | 2.5×-1.1× | 3.6×+0.5× | 3.1×+1.6× | 1.5×-3.3× | |
| Leverage | |||||
| Debt-to-equity | 0.4×-0.1× | 0.5×0.0× | 0.5×+0.2× | 0.3×+0.2× | |
| Net debt / EBITDA | 0.6×— | —— | —— | —— | |
| Per Share | |||||
| Book value per share | $10.76+18.0% | $9.12-2.8% | $9.38-62.2% | $24.78+590% | |
| Valuation | |||||
| Market capitalization | $3.76B+78.0% | $2.11B+2,866% | $71.18M-30.6% | $102.54M-99.7% | |
| Price / sales | 8.8×+1.9× | 6.9×+6.6× | 0.4×-0.1× | 0.4×-167× | |
| Price / book | 12.2×+3.6× | 8.6×+8.3× | 0.3×-0.1× | 0.4×-91.2× | |
| EV / EBITDA | 310.1×— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are GeneDx Holdings's profit margins?
- GeneDx Holdings (WGS) runs a 69.6% gross margin and a -14.9% operating margin, with a -17.6% net margin.
- Where do GeneDx Holdings's ratios come from?
- Every ratio is computed from GeneDx Holdings's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
